Notes from the Field: Nontuberculous Mycobacteria Infections in U.S. Medical Tourists Associated with Plastic Surgery — Dominican Republic, 2017
Weekly / March 30, 2018 / 67(12);369–370
Joanna Gaines, PhD1; Jose Poy, MD2; Kimberlee A. Musser, PhD3; Isaac Benowitz, MD4; Vivian Leung, MD5,6; Barbara Carothers7; Judy Kauerauf, MPH8; Noreen Mollon, MS9; Monique Duwell, MD5,10; Kathleen Henschel; MPH11; Alexandra De Jesus, MPH12; Sara K. Head, PhD13; Keun Lee, MPH1; Nelson Arboleda, MD14; Douglas H. Esposito, MD1 (View author affiliations)View suggested citation
Views equals page views plus PDF downloads
- pdf icon [PDF]
Since 2013, CDC has received reports and investigated serious complications among medical tourists (i.e., persons whose primary purpose for international travel is medical care) upon their return to the United States (1). On May 1, 2017, the New York City Department of Health and Mental Hygiene informed CDC of three patients with nontuberculous mycobacteria (NTM) surgical site infections (SSI), all of whom had undergone cosmetic surgical procedures by a single surgeon at Centro Internacional de Cirugía Plástica Avanzada (CIPLA) in the Dominican Republic (2).
To identify additional patients, calls for cases were issued via CDC’s Epidemic Information Exchange (Epi-X), state-based health alert systems, the Infectious Diseases Society of America’s Emerging Infections Network, and the American Society of Plastic Surgeons’ email distribution list. State and local health department staff members interviewed reported patients to collect information about medical care received abroad, symptoms, and treatment received after their original surgical procedures. A confirmed case of cosmetic surgery–associated NTM infection was defined as a diagnosed SSI and laboratory evidence confirming the presence of NTM in a U.S. resident who underwent a cosmetic surgery procedure in the Dominican Republic since January 1, 2017.
As of November 8, 2017, CDC had been notified of 52 patients from nine states with an SSI after cosmetic surgery in the Dominican Republic; 38 (73%) met the confirmed case definition. The remaining 14 did not have laboratory evidence of NTM and thus did not meet the confirmed case definition. All confirmed cases occurred in women who reported undergoing surgery during January 4–July 14, 2017 (Figure). Patients meeting the confirmed case definition identified 14 surgeons at seven surgical centers in the Dominican Republic (clinics A, B, C, D, E, CIPLA, and one unknown clinic). Among confirmed cases with available information, 26 (81%) of 32 patients reported undergoing surgery at CIPLA; 11 of 11 with information on treatment received more than one antibiotic, and 14 of 15 required therapeutic surgical procedures after returning to the United States. One death was reported.
The New York State Department of Health Wadsworth Center conducted whole genome sequencing of isolates from 22 cases and identified three distinct genetic cluster variants. None of the clusters corresponded to a single clinic or a single surgeon. NTM are ubiquitous in nature and commonly colonize water systems as a mix of clonal variants, which can make speciation less relevant in the context of an outbreak.
CDC notified public health authorities in the Dominican Republic of the investigation and issued a travel notice on July 18, 2017, advising U.S. residents of the risks associated with any surgery at CIPLA (2). CIPLA was temporarily closed on July 8, 2017.
Detection of outbreaks among medical tourists relies on clinical recognition and reporting to public health authorities. Patients who attend a single clinic abroad might be sparsely distributed across the United States. Furthermore, extrapulmonary NTM infections are not nationally notifiable and require targeted diagnostic testing, making cluster identification more difficult (3).
This investigation, in the context of medical tourism’s rapidly growing market, underscores the need for education of prospective medical tourists about possible risks and highlights the importance of health care providers having a high index of suspicion for NTM early in the evaluation of patients with SSI after cosmetic surgery (4). CDC continues to seek reports of infections after medical tourism from health departments. The Council of State and Territorial Epidemiologists recently approved a standard case definition to support improved surveillance for extrapulmonary NTM infections (3).
Kathy Seiber, Clinical and Environmental Microbiology Branch, Division of Healthcare Quality Promotion, National Center for Emerging and Zoonotic Infectious Diseases, CDC.
Conflict of Interest
No conflicts of interest were reported.
Corresponding author: Joanna Gaines, firstname.lastname@example.org, 404-639-4586.
1Travelers’ Health Branch, Division of Global Migration and Quarantine, National Center for Emerging and Zoonotic Infectious Diseases, CDC; 2New York City Department of Health and Mental Hygiene, Bureau of Communicable Disease; 3Wadsworth Center, New York State Department of Health; 4Prevention and Response Branch, Division of Healthcare Quality Promotion, National Center for Emerging and Zoonotic Infectious Diseases, CDC; 5Epidemiology Workforce Branch, Division of Scientific Education and Professional Development, Center for Surveillance, Epidemiology, and Laboratory Services, CDC; 6Connecticut Department of Public Health; 7New Jersey Department of Health, Communicable Disease Service; 8Illinois Department of Public Health, Communicable Disease Control Section; 9Michigan Department of Health and Human Services; 10Maryland Department of Health, Infectious Disease Epidemiology and Outbreak Response Bureau; 11Missouri Department of Health and Senior Services, Bureau of Communicable Disease Control and Prevention; 12Division of Epidemiology and Immunization, Massachusetts Department of Public Health, Bureau of Infectious Disease and Laboratory Sciences; 13Division of Epidemiology-Disease Surveillance and Investigation, District of Columbia Department of Health; 14Country Office, Dominican Republic, Division of Global HIV and TB, Center for Global Health, CDC.
- Schnabel D, Esposito DH, Gaines J, et al. Multistate US outbreak of rapidly growing mycobacterial infections associated with medical tourism to the Dominican Republic, 2013–2014. Emerg Infect Dis 2016;22:1340–7. CrossRefexternal icon PubMedexternal icon
- CDC. Nontuberculous mycobacteria in medical tourists to the Dominican Republic. Atlanta, GA: US Department of Health and Human Services, CDC; 2017. https://wwwnc.cdc.gov/travel/notices/alert/medical-tourism-dominican-republic
- Council of State and Territorial Epidemiologists. Standardized case definition for extrapulmonary nontuberculous mycobacteria infections. Position statement 17-ID-07. Atlanta, GA: Council of State and Territorial Epidemiologists; 2017. http://c.ymcdn.com/sites/www.cste.org/resource/resmgr/2017PS/2017PSFinal/17-ID-07.pdfpdf iconexternal icon
- Chen LH, Wilson ME. The globalization of healthcare: implications of medical tourism for the infectious disease clinician. Clin Infect Dis 2013;57:1752–9. CrossRefexternal icon PubMedexternal icon
FIGURE. Nontuberculous mycobacteria infections (N = 37) associated with cosmetic surgery among U.S. medical tourists, by clinic and month of procedure — Dominican Republic, January–July 2017
Abbreviation: CIPLA = Centro Internacional de Cirugía Plástica Avanzada.
The figure above is a bar chart showing the number of nontuberculous mycobacteria infections (N = 37) associated with cosmetic surgery among U.S. medical tourists, by clinic and month of procedure in the Dominican Republic during January–July 2017.
Suggested citation for this article: Gaines J, Poy J, Musser KA, et al. Notes from the Field: Nontuberculous Mycobacteria Infections in U.S. Medical Tourists Associated with Plastic Surgery — Dominican Republic, 2017. MMWR Morb Mortal Wkly Rep 2018;67:369–370. DOI: http://dx.doi.org/10.15585/mmwr.mm6712a5external icon.
MMWR and Morbidity and Mortality Weekly Report are service marks of the U.S. Department of Health and Human Services.
Use of trade names and commercial sources is for identification only and does not imply endorsement by the U.S. Department of Health and Human Services.
References to non-CDC sites on the Internet are provided as a service to MMWR readers and do not constitute or imply endorsement of these organizations or their programs by CDC or the U.S. Department of Health and Human Services. CDC is not responsible for the content of pages found at these sites. URL addresses listed in MMWR were current as of the date of publication.
All HTML versions of MMWR articles are generated from final proofs through an automated process. This conversion might result in character translation or format errors in the HTML version. Users are referred to the electronic PDF version (https://www.cdc.gov/mmwr) and/or the original MMWR paper copy for printable versions of official text, figures, and tables.
Questions or messages regarding errors in formatting should be addressed to email@example.com.